4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis

Kerstin Goebel*, Jan-Hendrik Wedell, Alexander M. Herrmann, Lydia Wachsmuth, Susann Pankratz, Stefan Bittner, Thomas Budde, Christoph Kleinschnitz, Cornelius Faber, Heinz Wiendl, Sven G. Meuth*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)62-71
JournalExperimental Neurology
Volume248
DOIs
Publication statusPublished - Oct 2013

Keywords

  • 4-Aminopyridine
  • Multiple sclerosis
  • EAE
  • Symptomatic treatment
  • Mobility

Cite this